Compounded oral drops require careful pharmacy and provider oversight
MindBodyPinnacle Health offers a hybrid model for your convenience
de Ceglia M, Decara J, Gaetani S, de Fonseca FR (2021) Obesity as a Condition determined by Food Addiction: should Brain Endocannabinoid System alterations be the cause and its Modulation the Solution
Rybelsus, the only oral GLP-1, is expected to be joined by Orforglipron by 2027-28
Together, these episodes explore how GLP-1 medications work, who theyre designed for, their potential benefits and risks, what were seeing both in practice and in the broader population, what the science says, and what active people need to know